On November 15, 2020, Acacia Research Corporation ("Acacia") announced that it has completed the monetization of its Woodford Life Science portfolio.  The company announced today that it has agreed to pay approximately $1 billion to acquire Oxford Nanopore Technologies, a microcap company.  According to the company's press release announcing the acquisition, Acacia's cash and equity investments totaled $605 million in the third quarter of 2020.  The company also announced that it has entered into a six-month lockup for its remaining shares.  According to the SEC's complaint, Acacia's cash and equity investments totaled just over $1 billion in the third quarter of 2020.  As a result of the acquisition, Acacia's net asset value increased from $285 million in the third quarter of 2018 to $336 million in the fourth quarter of 2020.  The company's financial results, which were reported on November 15, 2020, reflect the impact of the acquisition of Oxford Nanopore Technologies.  As a result of the acquisition of Oxford Nanopore Technologies, Acacia's net asset value increased from about $285 million in the third quarter to $336 million in the fourth quarter.  As a result of this acquisition, Acacia's net asset value increased by $33 million.  As a result of the transaction, Acacia's pro forma book value increased to $1 billion or $5.70 per share, up from $942.8 million or $5.70 per share as of June 30, 2021.  The company has entered into a six-month lockup agreement for its remaining shares until the expiry of the lockup.  The SEC's complaint, filed in the U.S. District Court for the Southern District of New York, charges Acacia with violations of the antifraud provisions of Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder.  The SEC's complaint charges Acacia with violations of Section 17(a)(1) of the Securities Act and Section 10(b) of the Exchange Act and Rule 10b-5 thereunder, and charges Acacia with violations of Rule 10b-5 thereunder.  Without admitting or denying the SEC's allegations, Acacia has consented to the entry of a final judgment that permanently restrains and enjoins it from violating Section 17(a) of the Securities Act, and orders it to pay disgorgement and prejudgment interest thereon.  The settlement is subject to court approval.  The SEC's investigation, which is continuing, is being conducted by Janney Montgomery